Odonate Therapeutics Performance
| ODTCDelisted Stock | USD 1.80 0.00 0.00% |
The company holds a Beta of -0.26, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Odonate Therapeutics are expected to decrease at a much lower rate. During the bear market, Odonate Therapeutics is likely to outperform the market. Odonate Therapeutics right now holds a risk of 0.0%. Please check Odonate Therapeutics maximum drawdown, as well as the relationship between the semi variance and rate of daily change , to decide if Odonate Therapeutics will be following its historical price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Odonate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Odonate Therapeutics is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 181.2 M | |
| Total Cashflows From Investing Activities | -432 K |
Odonate |
Odonate Therapeutics Relative Risk vs. Return Landscape
If you would invest 180.00 in Odonate Therapeutics on September 2, 2024 and sell it today you would earn a total of 0.00 from holding Odonate Therapeutics or generate 0.0% return on investment over 90 days. Odonate Therapeutics is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Odonate, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Odonate Therapeutics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Odonate Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Odonate Therapeutics, and traders can use it to determine the average amount a Odonate Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ODTC |
Based on monthly moving average Odonate Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Odonate Therapeutics by adding Odonate Therapeutics to a well-diversified portfolio.
Odonate Therapeutics Fundamentals Growth
Odonate Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Odonate Therapeutics, and Odonate Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Odonate Pink Sheet performance.
| Return On Equity | -0.86 | ||||
| Return On Asset | -0.33 | ||||
| Current Valuation | (26.67 M) | ||||
| Shares Outstanding | 38.49 M | ||||
| Price To Book | 0.89 X | ||||
| EBITDA | (125.91 M) | ||||
| Cash And Equivalents | 95.03 M | ||||
| Cash Per Share | 2.47 X | ||||
| Total Debt | 4.85 M | ||||
| Debt To Equity | 0.07 % | ||||
| Book Value Per Share | 1.85 X | ||||
| Cash Flow From Operations | (113.13 M) | ||||
| Earnings Per Share | (2.71) X | ||||
| Total Asset | 167.89 M | ||||
About Odonate Therapeutics Performance
By analyzing Odonate Therapeutics' fundamental ratios, stakeholders can gain valuable insights into Odonate Therapeutics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Odonate Therapeutics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Odonate Therapeutics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. The company was founded in 2013 and is based in New York, New York. Odonate Therapeutics operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 137 people.Things to note about Odonate Therapeutics performance evaluation
Checking the ongoing alerts about Odonate Therapeutics for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Odonate Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Odonate Therapeutics is not yet fully synchronised with the market data | |
| Odonate Therapeutics may become a speculative penny stock | |
| Odonate Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (126.35 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Odonate Therapeutics currently holds about 95.03 M in cash with (113.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.47, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Odonate Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Odonate Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining Odonate Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Odonate Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Odonate Therapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Odonate Therapeutics' pink sheet. These opinions can provide insight into Odonate Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Odonate Pink Sheet
If you are still planning to invest in Odonate Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Odonate Therapeutics' history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |